Evidence map›Paper›PMID 20061391›Full record

ArticleThe Journal of biological chemistry2010

Nuclear factor kappaB- and specificity protein 1-dependent p53-mediated bi-directional regulation of the human manganese superoxide dismutase gene.

Sanjit K Dhar, Yong Xu, Daret K St Clair

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
3.3field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 50 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Insights into the Dichotomous Regulation of SOD2 in Cancer.Antioxidants (Basel, Switzerland) · 2017
    Review
  8. Article
  9. Article
  10. p53 and mitochondrial function in neurons.Biochimica et biophysica acta · 2014
    Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Sanjit K DharGraduate Center for Toxicology, University of Kentucky, Lexington, Kentucky 40536.
Yong XuGraduate Center for Toxicology, University of Kentucky, Lexington, Kentucky 40536.
Daret K St ClairGraduate Center for Toxicology, University of Kentucky, Lexington, Kentucky 40536. Electronic address: dstcl00@uky.edu.
University of Kentucky · US

Funding

REDOX REGULATION OF TUMOR SUPPRESSION BY MNSODR01CA073599 · NCI · UNIVERSITY OF KENTUCKY · PI ST CLAIR, DARET K · 1998 to 2012
$4.0M
Mechansins of MnSOD expression in normal and tumor cellsR01CA049797 · NCI · UNIVERSITY OF KENTUCKY · PI ST CLAIR, DARET K · 1996 to 2014
$3.3M
MECHANISM OF MNSOD EXPRESSION IN NORMAL &TUMOR CELLSR29CA049797 · NCI · WAKE FOREST UNIVERSITY · PI ST CLAIR, DARET K · 1990 to 1994
–
NCI NIH HHS CA49797NCI NIH HHS CA73599NCI NIH HHS R01 CA049797NCI NIH HHS R01 CA073599
6 · The paper itself

Abstract

Tumor suppressor p53 is known to activate certain sets of genes while suppressing others. However, whether p53 can both activate and suppress the same gene is unclear. To address this question, concentration-dependent p53 effect on the manganese superoxide dismutase (MnSOD) gene was investigated. By transfecting p53 in PC-3 cells, we demonstrate that low concentrations of p53 increase while high concentrations suppress MnSOD expression. The physiological relevance of this effect was determined in vitro and in vivo using combined UVB-mediated activation and small interference RNA-mediated suppression of p53. Results were consistent with the bi-directional effect of p53 on MnSOD expression. MnSOD-promoter/enhancer analysis demonstrates that p53 is suppressive to the promoter activity regardless of the presence or absence of putative p53 binding sites. However, a low level of p53 increases MnSOD gene transcription in the presence of the intronic-enhancer element, and this effect is dependent on nuclear-factor kappaB (NF-kappaB) binding sites. Expression of p53 enhances nuclear levels of p65 with corresponding increase in the DNA-binding activity of NF-kappaB as detected by electrophoretic mobility shift and chromatin immunoprecipitation assays. Transfection of p65 small interference RNA reduces the positive effect of p53 on MnSOD gene transcription. These data suggest that p65 can overcome the negative effect of p53 on MnSOD expression. However, when the level of p53 was further increased, the suppressive effect of p53 outweighed the positive effect of p65 and led to the suppression of MnSOD gene transcription. These results demonstrated that p53 can both suppress and induce MnSOD expression depending on the balance of promoter and enhancer binding transcription factors.

Indexed as

Gene Expression Regulation, EnzymologicGenes, p53Binding SitesCell Line, TumorCell NucleusEnhancer Elements, GeneticHumansNF-kappa BPromoter Regions, GeneticReactive Oxygen SpeciesRNA, Small InterferingSp1 Transcription FactorSuperoxide DismutaseTranscription, GeneticTumor Suppressor Protein p53NF-kappa BReactive Oxygen SpeciesRNA, Small InterferingSp1 Transcription FactorSuperoxide DismutaseTP53 protein, humanTumor Suppressor Protein p53

Identifiers

PMID20061391
PMCPMC2843232
OpenAlexW2016582989

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.